Neurocrine Bioscience buy Guggenheim
Start price
06.05.25
/
50%
€108.15
Target price
06.05.26
€146.09
Performance (%)
2.17%
Price
09:30
€110.50
Summary
This prediction is currently active. The BUY prediction by Guggenheim shows slight gains of 2.17%. This prediction currently runs until 06.05.26. The prediction end date can be changed by Guggenheim at any time. Guggenheim has 50% into this predictionPerformance without dividends (%)
| Name | 1w | 1m |
|---|---|---|
| Neurocrine Bioscience | -1.296% | -1.296% |
| iShares Core DAX® | -6,02 % | -4,60 % |
| iShares Nasdaq 100 | 0,51 % | 0,16 % |
| iShares Nikkei 225® | -7,16 % | -2,21 % |
| iShares S&P 500 | -0,26 % | -0,84 % |
Comments by Guggenheim for this prediction
In the thread Neurocrine Bioscience diskutieren
Neurocrine Biosciences, Inc. (NASDAQ: NBIX) had its price target raised by analysts at Guggenheim from $155.00 to $165.00. They now have a "buy" rating on the stock.
Ratings data for NBIX provided by MarketBeat
Stopped prediction by Guggenheim for Neurocrine Bioscience
Neurocrine Bioscience
Start price
Target price
Perf. (%)
€120.00
10.02.25
10.02.25
€157.98
10.02.26
10.02.26
-2.54%
11.02.26
11.02.26
Neurocrine Bioscience
Start price
Target price
Perf. (%)
€140.30
02.08.24
02.08.24
€164.90
02.08.25
02.08.25
-21.03%
03.08.25
03.08.25
Neurocrine Bioscience
Start price
Target price
Perf. (%)
€131.25
02.05.24
02.05.24
€158.42
02.05.25
02.05.25
-26.05%
03.05.25
03.05.25